Lloyd Mack
Overview
Explore the profile of Lloyd Mack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hubner M, Kusamura S, Villeneuve L, Al-Niaimi A, Alyami M, Balonov K, et al.
Eur J Surg Oncol
. 2020 Aug;
46(12):2311-2323.
PMID: 32826114
Background: Enhanced recovery after surgery (ERAS) pathways have been shown to considerably reduce complications, length of stay and costs after most of surgical procedures by standardised application of best evidence-based...
12.
Hill W, Mack L, Webb C, Temple-Oberle C
Breast J
. 2020 Mar;
26(7):1490-1492.
PMID: 32223041
No abstract available.
13.
Nicholas C, Mack L, Webb C, Temple-Oberle C
Breast J
. 2020 Mar;
26(9):1909-1911.
PMID: 32223028
No abstract available.
14.
Schendel J, Jost E, Mah M, Mack L, McCall M, Gu N, et al.
Am J Surg
. 2020 Mar;
221(4):839-843.
PMID: 32222273
Background: As Canada's population ages, incidence of gastric cancer in elderly patients is increasing. There is little data on treatment and outcomes of gastric cancer in patients older than age...
15.
Choi K, Jost E, Mack L, Bouchard-Fortier A
Am J Surg
. 2020 Feb;
219(5):823-827.
PMID: 32029218
Introduction: Atypical lipomatous tumors or well-differentiated liposarcomas (ALT/WDLS) are low-grade soft tissue tumors that are commonly located on the trunk and extremities. There is no consensus on the best surgical...
16.
Are C, McMasters K, Giuliano A, Yanala U, Balch C, Anderson B, et al.
Ann Surg Oncol
. 2019 Mar;
26(6):1577-1582.
PMID: 30911947
No abstract available.
17.
Are C, McMasters K, Giuliano A, Balch C, Anderson B, Berman R, et al.
Ann Surg Oncol
. 2018 Jun;
25(8):2114-2116.
PMID: 29881928
No abstract available.
18.
Hurdle H, Bishop G, Walker A, Moazeni A, Paloucci E, Temple W, et al.
Can J Anaesth
. 2017 Aug;
64(11):1144-1152.
PMID: 28853010
Purpose: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) benefit patients with peritoneal carcinomatosis. Nevertheless, this therapy is associated with considerable postoperative pain due to the extensive abdominal incision. While...
19.
Chin-Lenn L, Craighead P, Bryant H, Mack L, Temple W, Ghali W, et al.
J Surg Oncol
. 2013 Sep;
108(6):348-51.
PMID: 24038038
Background And Objectives: Evaluation of the management of DCIS poses challenges, as standard breast cancer outcome measures such as mortality do not apply. We have developed quality indicators (QIs) to...
20.
McKay A, Motamedi M, Temple W, Mack L, Moore R
J Surg Oncol
. 2007 Apr;
96(2):151-9.
PMID: 17443742
Introduction: Involvement of critical vascular structures has historically been considered a contraindication to tumor resection. This study describes outcomes following radical oncologic resection with concomitant resection of critical vascular structures...